These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 19837985)
1. [MT1 melatonin receptors and their role in the oncostatic action of melatonin]. Danielczyk K; Dziegiel P Postepy Hig Med Dosw (Online); 2009 Sep; 63():425-34. PubMed ID: 19837985 [TBL] [Abstract][Full Text] [Related]
2. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia. Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972 [TBL] [Abstract][Full Text] [Related]
3. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288 [TBL] [Abstract][Full Text] [Related]
4. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies. Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981 [TBL] [Abstract][Full Text] [Related]
5. Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer. León J; Casado J; Carazo A; Sanjuán L; Maté A; Muñoz de Rueda P; de la Cueva P; Quiles R; Ruíz S; Ruíz-Extremera A; Salmerón J Mol Carcinog; 2012 Aug; 51(8):608-18. PubMed ID: 21809392 [TBL] [Abstract][Full Text] [Related]
6. Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease. Brunner P; Sözer-Topcular N; Jockers R; Ravid R; Angeloni D; Fraschini F; Eckert A; Müller-Spahn F; Savaskan E Eur J Histochem; 2006; 50(4):311-6. PubMed ID: 17213040 [TBL] [Abstract][Full Text] [Related]
7. MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective. Liu J; Clough SJ; Hutchinson AJ; Adamah-Biassi EB; Popovska-Gorevski M; Dubocovich ML Annu Rev Pharmacol Toxicol; 2016; 56():361-83. PubMed ID: 26514204 [TBL] [Abstract][Full Text] [Related]
9. The expression of MT1 melatonin receptor and Ki-67 antigen in melanoma malignum. Danielczyk K; Dziegiel P Anticancer Res; 2009 Oct; 29(10):3887-95. PubMed ID: 19846924 [TBL] [Abstract][Full Text] [Related]
10. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. Kaneko Y; Hayashi T; Yu S; Tajiri N; Bae EC; Solomita MA; Chheda SH; Weinbren NL; Parolini O; Borlongan CV J Pineal Res; 2011 Apr; 50(3):272-80. PubMed ID: 21269327 [TBL] [Abstract][Full Text] [Related]
11. Melatonin receptors in diabetes: a potential new therapeutical target? She M; Laudon M; Yin W Eur J Pharmacol; 2014 Dec; 744():220-3. PubMed ID: 25160745 [TBL] [Abstract][Full Text] [Related]
12. Human gastroenteropancreatic expression of melatonin and its receptors MT1 and MT2. Söderquist F; Hellström PM; Cunningham JL PLoS One; 2015; 10(3):e0120195. PubMed ID: 25822611 [TBL] [Abstract][Full Text] [Related]
13. Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain. Lacoste B; Angeloni D; Dominguez-Lopez S; Calderoni S; Mauro A; Fraschini F; Descarries L; Gobbi G J Pineal Res; 2015 May; 58(4):397-417. PubMed ID: 25726952 [TBL] [Abstract][Full Text] [Related]
14. Real-Time Determination of Intracellular cAMP Reveals Functional Coupling of G Tse LH; Cheung ST; Lee S; Wong YH Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474167 [TBL] [Abstract][Full Text] [Related]
15. Gene structures, biochemical characterization and distribution of rat melatonin receptors. Ishii H; Tanaka N; Kobayashi M; Kato M; Sakuma Y J Physiol Sci; 2009 Jan; 59(1):37-47. PubMed ID: 19340560 [TBL] [Abstract][Full Text] [Related]
16. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression. Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic actions of melatonin in cancer: possible mechanisms. Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of melatonin treatment in primary culture of canine mammary tumors. Lopes JR; Maschio LB; Jardim-Perassi BV; Moschetta MG; Ferreira LC; Martins GR; Gelaleti GB; De Campos Zuccari DA Oncol Rep; 2015 Jan; 33(1):311-9. PubMed ID: 25384569 [TBL] [Abstract][Full Text] [Related]
19. New selective ligands of human cloned melatonin MT1 and MT2 receptors. Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the daily changes of melatonin receptors in the rat liver. Venegas C; García JA; Doerrier C; Volt H; Escames G; López LC; Reiter RJ; Acuña-Castroviejo D J Pineal Res; 2013 Apr; 54(3):313-21. PubMed ID: 23110416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]